Neurava raised $2.26M in a Series Seed round led by Life Science Angels, used for pivotal usability study and FDA clearance

Apr 03, 2024•over 1 year ago

Amount Raised

$2.26 Million

BaltimoreInformation Technology

Investors

First Leaf CapitalRivermount VenturesElevate VenturesPurdue InnovatesUcbLife Science Angels

Description

Neurava completed an oversubscribed Series Seed round, raising $2.26 million to develop innovative wearable devices for epilepsy monitoring to mitigate the risk of SUDEP, with the funding used for pivotal usability study, establishing manufacturing partners, and seeking FDA clearance.

Company Information

Company

Neurava

Location

101 W Dickman Street, Suite 807

Baltimore, Maryland, United States

About

Neurava is a medical technology company developing AI-powered wearable solutions to transform outcomes in areas of unmet clinical need, starting with epilepsy. Founded in 2019 by Vivek Ganesh, PhD, and Jay Shah, PhD, later joined by Trevor Meyer, PhD, Neurava leverages deep expertise in neuromodulation and epilepsy to create devices that monitor seizures and related cardiorespiratory dysfunctions—ultimately aiming to reduce the risk of SUDEP and provide peace of mind to patients and families.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns